Noom Launches Microdose GLP-1 Program, Enabling Weight Loss Without the Side Effects and Priced at $119 to Start, Including Medication and Microhabits Program 70% of Noom members receiving microdoses of GLP-1 with lifestyle support report no side effects, while experiencing significant weight loss and overall health gains The program addresses all three major barriers to bending the obesity curve in the US: excessive US prices of medication, medication side effects, and sustainable lifestyle change NEW YORK, Aug
Clinical trials suggest retatrutide dosing will start low, with incremental increase every four weeks, similarly to drugs like Zepbound and Wegovy
Supports healthy weight management: by curbing cravings and stabilising blood sugar, it helps you maintain or reduce weight more easily
Modified from Lim et al
Do not independently use a dose change as a nausea-management strategy
2 Less than 1% of patients in an efficacy and safety trial reported a skin adverse event